Can-Fite BioPharma Ltd. Earnings Per Share (Basic)
Can-Fite BioPharma Ltd. (CANF) reported Earnings Per Share (Basic) of -$5.97 per share for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-03-26
| Period end | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | -$5.97 20-F · filed 2026-03-26 | ||
| 2025-06-30 | $0.00 6-K · filed 2025-08-28 | ||
| 2024-12-31 | -$10.86 20-F · filed 2026-03-26 | $0.00 20-F · filed 2025-04-14 | |
| 2024-06-30 | $0.00 6-K · filed 2025-08-28 | ||
| 2023-12-31 | -$17.92 20-F · filed 2026-03-26 | -$0.01 20-F · filed 2024-03-28 | |
| 2023-06-30 | $0.00 6-K · filed 2024-08-29 | ||
| 2022-12-31 | -$0.01 20-F · filed 2025-04-14 | ||
| 2022-06-30 | $0.00 6-K · filed 2023-08-31 | ||
| 2021-12-31 | -$0.03 20-F · filed 2024-03-28 | ||
| 2021-06-30 | -$0.01 6-K · filed 2022-08-25 | ||
| 2020-12-31 | -$0.04 20-F · filed 2023-03-30 |